Citius Pharmaceuticals Inc (NASDAQ:CTXR)
| 0.9963 Delayed Data As of Mar 23 |  +0.0062 / +0.63%Today’s Change | 0.77 Today|||52-Week Range 2.01 | +26.11% Year-to-Date |
Latest CTXR News | Press Releases
No recent news for Citius Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.99 |
| Today’s open | 1.01 |
| Day’s range | 0.99 - 1.03 |
| Volume | 6,293 |
| Average volume (3 months) | 744,497 |
| Market cap | $147.7M |
Data as of 3:56pm ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -2.08% |
| Earnings growth (this year) | +34.78% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSGTFGensight Biologics S... | 0.00 | 0.00% |
| GTHXG1 Therapeutics Inc | -0.25 | -8.77% |
| SPPISpectrum Pharmaceuti... | -0.02 | -2.37% |
| SPHDFSanthera Pharmaceuti... | 0.00 | 0.00% |
Data as of 3:59pm ET, 03/23/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.04 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$33.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Cranford, New Jersey |
Forecasts
